Darkwind
Diamond Member
- Jun 18, 2009
- 34,860
- 19,389
You miss the point. The judge should not have been involved at all, nor even consulted.Charlie Guard is a tragic case, and I extend my sympathies to his parents, but it is worth while to read at least part of the judges ruling
Read full summary of judge's ruling over baby Charlie Gard's life support
"I was aware that I was to hear evidence from the doctor in the USA who was, reportedly, offering what had been referred to as pioneering treatment. Before he gave evidence, I encouraged the treating consultant at GOSH to speak with him, which she was able and willing to do. I am truly grateful to these experts for the time that they have given to this case. The outcome of that discussion is illuminating and the doctor in the USA said the following:
'Seeing the documents this morning has been very helpful. I can understand the opinions that he is so severely affected by encelopathy that any attempt at therapy would be futile. I agree that it is very unlikely that he will improve with that therapy. It is unlikely.'
"However, the US doctor made it clear that, were Charlie in the US, he would treat him if the parents so desired and could pay for it. As I have already said, funding in this case is not in issue. The US doctor also confirmed during this telephone conversation that he had never treated with nucleoside therapy anyone who had encephalopathy, therefore he was unable to indicate from any scientific basis whether a patient with encephalopathy would respond positively.
"Charlie suffers from the RRM2B mutation of MDDS. No one in the world has ever treated this form
of MDDS with nucleoside therapy, although patients with a different strain, TK2, have received nucleoside therapy, with some recorded benefit. In mouse models the benefit to TK2 patients was put at 4% of life expectancy. There is no evidence that nucleoside therapy can cross the blood/brain barrier, which it must do to treat RRM2B, although the US doctor expressed the hope that it might do so. There is unanimity among the experts from whom I have heard that nucleoside therapy cannot reverse structural brain damage. I dare say that medical science may benefit, objectively, from the experiment, but experimentation cannot be in Charlie's best interests unless there is a prospect of benefit for him.
"The GOSH team believe that Charlie can probably experience pain, but is unable to react to it in a meaningful way. Their evidence was that being ventilated, being suctioned, living as Charlie does, are all capable of causing pain. Transporting Charlie to the USA would be problematic, but possible. Subjecting him to nucleoside therapy is unknown territory, for it has never even been tested even on mouse models, but it may (or may not) subject the patient to pain, possibly even to mutations. But if Charlie's damaged brain function cannot be improved, as all agree, then how can he be any better off than he is now, which is a condition that his parents believe should not be sustained?
"It is with the heaviest of hearts, but with complete conviction for Charlie's best interests, that I find it is in Charlie's best interests that I accede to these applications and rule that GOSH may lawfully withdraw all treatment save for palliative care to permit Charlie to die with dignity.
"I want to thank the team of experts and carers at GOSH, and others who cannot be named, for the extraordinary care that they have provide to this family. Most importantly of all, I want to thank Charlie's parents for their brave and dignified campaign on his behalf, but more than anything to pay tribute to their absolute dedication to their wonderful boy, from the day that he was born."